ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 35 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $388,000 | -1.5% | 776,313 | 0.0% | 0.00% | – |
| Q3 2016 | $394,000 | -49.2% | 776,313 | 0.0% | 0.00% | – |
| Q2 2016 | $776,000 | +33.1% | 776,313 | -9.0% | 0.00% | – |
| Q1 2016 | $583,000 | -43.5% | 852,854 | 0.0% | 0.00% | – |
| Q4 2015 | $1,032,000 | -45.5% | 852,854 | +0.5% | 0.00% | – |
| Q3 2015 | $1,892,000 | -14.7% | 848,654 | -10.9% | 0.00% | – |
| Q2 2015 | $2,219,000 | +17.0% | 952,292 | +7.9% | 0.00% | – |
| Q1 2015 | $1,897,000 | -1.4% | 882,319 | +5.1% | 0.00% | – |
| Q4 2014 | $1,923,000 | -11.4% | 839,589 | +3.3% | 0.00% | – |
| Q3 2014 | $2,170,000 | -14.9% | 812,625 | +18.9% | 0.00% | – |
| Q2 2014 | $2,549,000 | -71.3% | 683,312 | -9.7% | 0.00% | -100.0% |
| Q1 2014 | $8,894,000 | +34.4% | 756,319 | -4.7% | 0.00% | +100.0% |
| Q4 2013 | $6,618,000 | +19.3% | 793,486 | +32.6% | 0.00% | 0.0% |
| Q3 2013 | $5,546,000 | +2.7% | 598,310 | +8.6% | 0.00% | 0.0% |
| Q2 2013 | $5,399,000 | – | 550,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu KCG Holdings LLC | 86,824 | $31,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $17,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,405 | $0 | 0.00% |
| CITIGROUP INC | 9,751 | $4,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,281 | $6,000 | 0.00% |
| MORGAN STANLEY | 4,250 | $2,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 48,944 | $18,000 | 0.00% |
| BlackRock Inc. | 927,688 | $334,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 6,600 | $2,000 | 0.00% |
| Bank of New York Mellon Corp | 62,846 | $22,000 | 0.00% |